Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 5.
FIG. 5.

Pyruvate carboxylase (PC) ASO improves hepatic insulin sensitivity in HFF rats. Fasting plasma glucose (A) and insulin concentration (B) (n = 9 per group). C: Basal endogenous glucose production (n = 9 per group). Plasma glucose concentration (D) and glucose infusion rate time course (E) during hyperinsulinemic-euglycemic (4 mU/kg per min) clamp, respectively (n = 7–8 per group). Insulin-stimulated peripheral glucose metabolism (F), endogenous glucose production (G), and percentage suppression of endogenous glucose production (H) during clamp (n = 7–8 per group). *P < 0.05, **P < 0.01, and ***P < 0.001 compared with control ASO group. Experiments were done at 4–5 weeks of treatment.

This Article

  1. Diabetes vol. 62 no. 7 2183-2194